期刊文献+

口服枸橼酸铁铵MRCP诊断低位梗阻性黄疸的价值 被引量:2

Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice
下载PDF
导出
摘要 目的:评价口服枸橼酸铁铵MRCP在低位梗阻性黄疸诊断中的应用价值。方法:对36例拟诊低位梗阻性黄疸的病人行口服枸橼酸铁铵前后MRCP及常规胆胰系MRI,据此进行定位、定性诊断,并与B超,CT,ERCP及手术和病理结果相比较。结果:口服枸橼酸铁铵后MRCP图像质量明显提高,对低位梗阻性黄疸的定位定性诊断准确率达97.22%,优于B超(P<0.05),与CT,ERCP无显著差异。结论:口服枸橼酸铁铵后MRCP结合常规MRI在低位梗阻性黄疸的定位、定性诊断上具有很高的准确性,是一种安全、简便、无创伤的诊断方法。 Objective To evaluate the value of oral ferric ammonium citrate solution as a gastrointestinal contrast agent in diagnosing low-level obstructive jaundice. Methods Thirty-six patients who were suspected of low-level obstructive jaundice were performed with magnetic resonance cholangiopancreatography (MRCP) and conventional MRI before and after the administration of oral ferric ammonium citrate solution. The diagnostic accuracy for evaluating the site and the cause of obstruction was compared with other diagnostic modalities. Results The image qualities of single-slice and multi-slice MRCP were improved markedly. The accuracy of MRCP for evaluating the site of obstruction was 97.22% , which was superior to US (P 〈 0.05 ). There were no significant differences among the MRCP, CT, and ERCP. Conclusion Oral ferric ammonium citrate solution can significandy improve the image quality of MRCP. FAC-MRCP is a simple, safe, and noninvasive technique with excellent accuracy in the diagnosis of low-level obstructive jaundice.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2007年第2期347-350,共4页 Journal of Central South University :Medical Science
关键词 低位梗阻性黄疸 磁共振成像 枸橼酸铁铵 胆道梗阻 low-level obstructive jaundice magnetic resonance imaging ferric ammonium citrate bile duct obstruction
  • 相关文献

参考文献10

  • 1Giovagnoni A,Fabbri A,Maccioni F,et al.Oral contrast agents in MRI of the gastrointestinal tract[J].Abdom Imaging,2002,27(4):367-375.
  • 2Aube C,Lebigot J,Pessaux P,et al.Evaluation of the permeability of pancreaticogastric anastomoses (PGA) with dynamic magnetic resonance pancreatography after secretin stimulation (secretin MRCP)[J].Abdom Imaging,2003,28(4):563-570.
  • 3Papanikolaou N,Karantanas A,Maris T,et al.MR cholangiopancreatography before and after oral blueberry juice administration[J].J Comput Assist Tomogr,2000,24(2):229-234.
  • 4Chan J H,Tsui E Y,Yuen M K,et al.Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP[J].Abdom Imaging,2000,25(4):405-408.
  • 5袁友红,肖恩华,卓尚丕.枸橼酸铁铵泡腾颗粒在上腹部MRI扫描中的初步应用[J].临床放射学杂志,2005,24(10):931-933. 被引量:6
  • 6Malcolm P N,Brown J J,Hahn P F,et al.The clinical value of ferric ammonium citrate:a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen[J].J Magn Reson Imaging,2000,12(5):702-707.
  • 7Kivelitz D,Gehl H B,Heuck A,et al.Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen:safety and diagnostic efficacy[J].Acta Radiol,1999,40(4):429-435.
  • 8Takahara T,Saeki M,Nosaka S,et al.The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent:application in MR cholangiography[J].Nippon Igaku Hoshasen Gakkai Zasshi,1995,55(9):697-699.
  • 9Kato J,Kawamura Y,Watanabe T,et al.Examination of intra-gastrointestinal tract signal elimination in MRCP:combined use of T(1)-shortening positive contrast agent and single-shot fast inversion recovery[J].J Magn Reson Imaging,2001,13(5):738-743.
  • 10Patten R M,Lo S K,Phillips J J,et al.Positive bowel contrast agent for MR imaging of the abdomen:phase Ⅱ and Ⅲ clinical trials[J].Radiology,1993,189(1):277-283.

二级参考文献9

  • 1张立娜,徐克,任克,孙文阁,戚喜勋,金安玉,李延亮.使用枸橼酸铁铵抑制3D-MRCP图像中胃肠信号的初步研究[J].中国医学影像技术,2003,19(6):762-764. 被引量:15
  • 2戴平丰,刘继汉,余伟南.腹部磁共振成像应用口服造影剂枸橼酸铁铵的研究[J].中华放射学杂志,1994,28(6):407-411. 被引量:12
  • 3Brown JJ. Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin N Am, 1996, 4:25
  • 4Ohgi K, Satoh K, Tanaka S,et al. Elimination of artifacts in MRCP: technical consideration. Nippon Rinsho, 1998, 56:2854
  • 5Unger EC, Fritz TA, Palestrant D,et al. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent. J Magn Reson Imaging, 1993, 3:119
  • 6Kato J, Kawamura Y, Watanabe T,et al. Examination of intra-gastrointestinal tract signal elimination in MRCP: combined use of T(1)-shortening positive contrast agent and single-shot fast inversion recovery. J Magn Reson Imaging, 2001, 13:738
  • 7Malcolm PN, Brown JJ, Hahn PF,et al. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen. J Magn Reson Imaging, 2000, 12:702
  • 8Kivelitz D, Gehl HB, Heuck A,et al. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy. Acta Radiol, 1999, 40:429
  • 9Patten RM, Lo SK, Phillips JJ,et al. Positive bowel contrast agent for MR imaging of the abdomen: phase Ⅱ and Ⅲ clinical trials. Radiology, 1993, 189:277

共引文献5

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部